Eric Forman, 10% Owner at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT.OB), bought 36,500 shares at $0.25 ($625) on 2016-02-04, disclosed to the SEC on 2016-02-04.
Open-market purchase of $625 LIXT.OB by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 34,000 | $0 | 0.0% |
| 2 | $0.25 | 2,500 | $625 | 100.0% |
| Total | $0.02 avg | 36,500 | $625 | 100% |
| Filing → |
| LIXT | BUY | 2022-11-21 | $12K | — | Filing → |
| LIXT.OB | BUY | 2016-02-19 | $16K | — | Filing → |